Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.
about
Chemokine receptor CXCR4 regulates CaMKII/CREB pathway in spinal neurons that underlies cancer-induced bone pain.Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.Neuropathic Pain: Central vs. Peripheral Mechanisms.Breaking barriers to novel analgesic drug development.SDF1-CXCR4 Signaling Maintains Central Post-Stroke Pain through Mediation of Glial-Neuronal Interactions
P2860
Early Repeated Administration of CXCR4 Antagonist AMD3100 Dose-Dependently Improves Neuropathic Pain in Rats After L5 Spinal Nerve Ligation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@en
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@nl
type
label
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@en
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@nl
prefLabel
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@en
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@nl
P2093
P2860
P1476
Early Repeated Administration ...... fter L5 Spinal Nerve Ligation.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11064-016-1943-8
P577
2016-05-11T00:00:00Z